Published in Arch Clin Neuropsychol on June 09, 2013
Improving clinical cognitive testing: report of the AAN Behavioral Neurology Section Workgroup. Neurology (2015) 0.76
Mild Cognitive Impairments Moderate the Effect of Time on Verbal Fluency Performance. J Int Neuropsychol Soc (2016) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Mild cognitive impairment as a diagnostic entity. J Intern Med (2004) 26.95
The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol (2009) 4.96
Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol (1999) 4.38
Clinical practice. Mild cognitive impairment. N Engl J Med (2011) 4.16
Norms for letter and category fluency: demographic corrections for age, education, and ethnicity. Assessment (1999) 3.47
Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. Arch Gen Psychiatry (2006) 3.44
Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol (2008) 3.39
Conversion from subtypes of mild cognitive impairment to Alzheimer dementia. Neurology (2007) 3.02
Mild cognitive impairment: long-term course of four clinical subtypes. Neurology (2006) 2.93
Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol (2002) 2.68
Is MCI really just early dementia? A systematic review of conversion studies. Int Psychogeriatr (2004) 2.54
Verbal fluency performance in dementia of the Alzheimer's type: a meta-analysis. Neuropsychologia (2004) 2.39
Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord (2006) 2.01
Role of frontal versus temporal cortex in verbal fluency as revealed by voxel-based lesion symptom mapping. J Int Neuropsychol Soc (2006) 1.77
The effects of focal anterior and posterior brain lesions on verbal fluency. J Int Neuropsychol Soc (1998) 1.59
Verbal fluency performance in amnestic MCI and older adults with cognitive complaints. Arch Clin Neuropsychol (2008) 1.51
A meta-analytic review of verbal fluency performance following focal cortical lesions. Neuropsychology (2004) 1.46
Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Dement Geriatr Cogn Disord (2007) 1.35
Predictive accuracy of MCI subtypes for Alzheimer's disease and vascular dementia in subjects with mild cognitive impairment: a 2-year follow-up study. Dement Geriatr Cogn Disord (2004) 1.34
To err is human: "abnormal" neuropsychological scores and variability are common in healthy adults. Arch Clin Neuropsychol (2009) 1.27
Verbal fluency patterns in amnestic mild cognitive impairment are characteristic of Alzheimer's type dementia. J Int Neuropsychol Soc (2006) 1.24
Examining the range of normal intraindividual variability in neuropsychological test performance. J Int Neuropsychol Soc (2003) 1.22
Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes. Arch Neurol (2008) 1.22
Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia. Dement Geriatr Cogn Disord (2007) 1.20
Base rates of "impaired" neuropsychological test performance among healthy older adults. Arch Clin Neuropsychol (1998) 1.18
Semantic knowledge in mild cognitive impairment and mild Alzheimer's disease. Cortex (2006) 1.17
Two-year outcome of MCI subtypes and aetiologies in the Göteborg MCI study. J Neurol Neurosurg Psychiatry (2009) 1.15
Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes. Arch Neurol (2009) 1.11
Clustering and switching strategies during verbal fluency performance differentiate Alzheimer's disease and healthy aging. J Int Neuropsychol Soc (2011) 1.01
Lexical and semantic fluency discrepancy scores in aMCI and early Alzheimer's disease. J Neuropsychol (2009) 0.99
Semantic verbal fluency strategies in amnestic mild cognitive impairment. Neuropsychology (2012) 0.94
Effects of age, education and gender on verbal fluency. J Clin Exp Neuropsychol (2003) 0.94
Morphological cerebral correlates of CERAD test performance in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis (2011) 0.93
Persistence of neuropsychological testing deficits in mild cognitive impairment. Dement Geriatr Cogn Disord (2009) 0.92
'Normal' semantic-phonemic fluency discrepancy in Alzheimer's disease? A meta-analytic study. Cortex (2009) 0.91
Patterns of word-list generation in mild cognitive impairment and Alzheimer's disease. Clin Neuropsychol (2009) 0.90
Age-related differences in performance of phonemic verbal fluency measured by Controlled Oral Word Association Task (COWAT): a meta-analytic study. Dev Neuropsychol (2006) 0.87
Verbal fluency deficits co-occur with memory deficits in geriatric patients at risk for dementia: Implications for the concept of mild cognitive impairment. Behav Neurol (2010) 0.82
Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med (2012) 14.14
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther (2011) 2.51
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.30
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.25
Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol Aging (2004) 2.23
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain (2007) 1.99
Lifespan trajectory of myelin integrity and maximum motor speed. Neurobiol Aging (2008) 1.92
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond) (2012) 1.90
Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging (2006) 1.87
Comparison of AdaBoost and support vector machines for detecting Alzheimer's disease through automated hippocampal segmentation. IEEE Trans Med Imaging (2009) 1.80
Common Alzheimer's disease risk variant within the CLU gene affects white matter microstructure in young adults. J Neurosci (2011) 1.74
Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem Res (2007) 1.63
Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci U S A (2007) 1.52
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet (2012) 1.46
Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease. Sci Transl Med (2014) 1.45
Gain-of-function mutations of ARHGAP31, a Cdc42/Rac1 GTPase regulator, cause syndromic cutis aplasia and limb anomalies. Am J Hum Genet (2011) 1.41
The C-terminus of connexin43 adopts different conformations in the Golgi and gap junction as detected with structure-specific antibodies. Biochem J (2007) 1.38
Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease. Dement Geriatr Cogn Disord (2007) 1.35
Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch Neurol (2012) 1.32
The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: an additional fifteen families. Neurogenetics (2006) 1.31
A Slit/miR-218/Robo regulatory loop is required during heart tube formation in zebrafish. Development (2011) 1.31
Automatic subcortical segmentation using a contextual model. Med Image Comput Comput Assist Interv (2008) 1.25
Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann N Y Acad Sci (2004) 1.23
Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. Arch Gen Psychiatry (2006) 1.22
Effects of ApoE4 and maternal history of dementia on hippocampal atrophy. Neurobiol Aging (2010) 1.22
Src-dependent tyrosine phosphorylation at the tips of growth cone filopodia promotes extension. J Neurosci (2005) 1.21
Brain maturation may be arrested in chronic cocaine addicts. Biol Psychiatry (2002) 1.20
Time-lapse mapping of cortical changes in schizophrenia with different treatments. Cereb Cortex (2008) 1.20
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension. Hum Mutat (2011) 1.18
Impaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology (2013) 1.16
Multimodal magnetic resonance imaging assessment of white matter aging trajectories over the lifespan of healthy individuals. Biol Psychiatry (2012) 1.15
Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease. Mol Neurodegener (2010) 1.15
Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions. Biol Psychiatry (2012) 1.13
Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid. Arch Neurol (2009) 1.12
In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophr Res (2009) 1.12
Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study. Biol Psychiatry (2003) 1.12
Human brain myelination and amyloid beta deposition in Alzheimer's disease. Alzheimers Dement (2007) 1.10
Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer's disease. J Alzheimers Dis (2004) 1.09
Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study. J Alzheimers Dis (2011) 1.09
Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder. Biol Psychiatry (2005) 1.09
Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia. Biol Psychiatry (2007) 1.08
3D mapping of mini-mental state examination performance in clinical and preclinical Alzheimer disease. Alzheimer Dis Assoc Disord (2006) 1.06
Neuroimaging measures as endophenotypes in Alzheimer's disease. Int J Alzheimers Dis (2011) 1.04
Utility of the functional activities questionnaire for distinguishing mild cognitive impairment from very mild Alzheimer disease. Alzheimer Dis Assoc Disord (2014) 1.03
Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative. Neurobiol Aging (2012) 1.02
Subtle deficits in instrumental activities of daily living in subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord (2010) 1.01
Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia. Schizophr Res (2012) 1.01
The Thr354Ile substitution in PSEN1:: disease-causing mutation or polymorphism? Neurology (2006) 1.00
Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging. J Alzheimers Dis (2013) 1.00
Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation. Neurosci Lett (2010) 1.00
Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory. Schizophr Res (2011) 0.99
Relationship of a variant in the NTRK1 gene to white matter microstructure in young adults. J Neurosci (2012) 0.97
Children of persons with Alzheimer disease: what does the future hold? Alzheimer Dis Assoc Disord (2008) 0.97
Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations. J Neurol Neurosurg Psychiatry (2012) 0.97
Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease. Brain Imaging Behav (2012) 0.96
Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychopharmacology (2011) 0.96
Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria. Am J Geriatr Psychiatry (2008) 0.96
Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci U S A (2012) 0.95
Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr Res (2007) 0.94
Verbal memory is associated with structural hippocampal changes in newly diagnosed Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 0.93
Age-related slowing in cognitive processing speed is associated with myelin integrity in a very healthy elderly sample. J Clin Exp Neuropsychol (2011) 0.93
The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study. Neurology (2013) 0.92
Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease. Brain Imaging Behav (2012) 0.92
Myelin breakdown mediates age-related slowing in cognitive processing speed in healthy elderly men. Brain Cogn (2012) 0.92
Persistence of neuropsychological testing deficits in mild cognitive impairment. Dement Geriatr Cogn Disord (2009) 0.92
Deficits in facial emotion processing in mild cognitive impairment. Dement Geriatr Cogn Disord (2007) 0.91
Multilocus genetic profiling to empower drug trials and predict brain atrophy. Neuroimage Clin (2013) 0.89
Complexity and synchronicity of resting state blood oxygenation level-dependent (BOLD) functional MRI in normal aging and cognitive decline. J Magn Reson Imaging (2012) 0.89
Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease. Dement Geriatr Cogn Disord (2011) 0.88
Genetic architecture of resilience of executive functioning. Brain Imaging Behav (2012) 0.87
Comparison of clinical characteristics between familial and non-familial early onset Alzheimer's disease. J Neurol (2012) 0.87
Reduced quality-of-life ratings in mild cognitive impairment: analyses of subject and informant responses. Am J Geriatr Psychiatry (2012) 0.87
Establishing magnetic resonance images orientation for the EADC-ADNI manual hippocampal segmentation protocol. J Neuroimaging (2013) 0.86
Clinical, FDG and amyloid PET imaging in posterior cortical atrophy. J Neurol (2015) 0.86
Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men. J Alzheimers Dis (2010) 0.86
Cortical gray matter volumes are associated with subjective responses to cocaine infusion. Am J Addict (2004) 0.85
Developing an integrated treatment for substance use and depression using cognitive-behavioral therapy. J Subst Abuse Treat (2009) 0.85
Methodological improvements in voxel-based analysis of diffusion tensor images: applications to study the impact of apolipoprotein E on white matter integrity. J Magn Reson Imaging (2013) 0.84
Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there? Expert Rev Neurother (2006) 0.84
Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol (2015) 0.84
The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease. Contemp Clin Trials (2013) 0.84
Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging. Am J Physiol Heart Circ Physiol (2013) 0.83
Alzheimer Disease. Continuum (Minneap Minn) (2016) 0.83
Chronic aspartame affects T-maze performance, brain cholinergic receptors and Na+,K+-ATPase in rats. Pharmacol Biochem Behav (2004) 0.83
Agitation and psychosis associated with dementia with lewy bodies exacerbated by modafinil use. Am J Alzheimers Dis Other Demen (2012) 0.82
Alzheimer disease: 'generation next' in Alzheimer disease genetic studies. Nat Rev Neurol (2013) 0.82
Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease. Mov Disord (2013) 0.82
Chinese-language montreal cognitive assessment for cantonese or mandarin speakers: age, education, and gender effects. Int J Alzheimers Dis (2012) 0.82